Skip to main content
Have a personal or library account? Click to login
Immunogenetic Manifestations of Lyme Borreliosis / Imūnìenģtiskās Izpausmes Laimboreliozes Gadījumā Cover

Immunogenetic Manifestations of Lyme Borreliosis / Imūnìenģtiskās Izpausmes Laimboreliozes Gadījumā

Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences.
Volume 70 (2016): Issue 4 (August 2016)
By: ,  ,  ,  ,   and    
Open Access
|Aug 2016
References

References

  1. Abramowicz, M. (2000). Treatment of Lyme disease. Med. Letter, 42, 37-39.
    Search in Google Scholar
  2. Anonymous (2008). Reported Cases of Lyme Disease by Year, 2007, United States, 1991-2006. September 27, 2007 (cited 2008 March 26); Available at: http://www.cdc.gov/ncidod/dvbid/lyme/ld_UpClimbLymeDis.htm.
    Search in Google Scholar
  3. Anonymous (2012). Categorical data analysis using the SAS system.
    Search in Google Scholar
  4. Anonymous (2014). Statistical data on incidence of infectious diseases in Latvia 2014. Available at: http://www.ecdc.europa.eu/en/publications/publications/tbe-in-euefta. pdf (accessed 03.06.2016).
    Search in Google Scholar
  5. Auwaerter, P. G., Aucott, J., Dumler, J. S. (2004). Lyme borreliosis (Lyme disease): Molecular and cellular pathobiology and prospects for prevention, diagnosis and treatment. Expert Rev. Mol. Med., 6 (2), 1-22.
    Open DOISearch in Google Scholar
  6. Auwaerter, P. G. (2007). Point: antibiotic therapy is not the answer for patients with persisting symptoms attributable to Lyme disease. Clin. Infect. Dis., 45 (2), 143-148.
    Open DOISearch in Google Scholar
  7. Bateman, H., Sigal, L. (2000). Update on Lyme Carditis. Curr. Infect. Dis. Rep., 2 (4), 299-301.
    Open DOISearch in Google Scholar
  8. Bunikis, J., Barbour, A. G. (2002). Laboratory testing for suspected Lyme disease. Med. Clin. North Amer., 86 (2), 311-340.
    Open DOISearch in Google Scholar
  9. Fallon, B. A., Keilp, J. G., Corbera, K. M., Petkova, E., Britton, C. B., Dwyer, E., Slavov, I., Cheng, J., Dobkin, J., Nelson, D. R., Sackeim, H. A. (2008). A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy. Neurology, 70 (13), 992-1003.
    Open DOISearch in Google Scholar
  10. Feder, H. M. Jr, Johnson, B. J. B., O’Connell, S., Shapiro, E. D., Steere, A. C., Wormser, G. P. (2007). The Ad Hoc International Lyme Disease Group. A critical appraisal of Chronic Lyme Disease. New Engl. J. Med., 357, 1422-1430.
    Open DOISearch in Google Scholar
  11. Fleming, R. V., Marques, A. R., Klempner, M. S., Schmid, C. H., Dally, L. G., Martin, D. S., Philipp, M. T. (2004). Pre-treatment and post-treatment assessment of the C(6) test in patients with persistent symptoms and a history of Lyme borreliosis. Eur. J. Clin. Microbiol. Infect. Dis., 23 (8), 615-618.
    Open DOISearch in Google Scholar
  12. Halperin, J. J. (2003). Lyme disease and the peripheral nervous system. Muscle Nerve, 28 (2), 133-143.
    Open DOISearch in Google Scholar
  13. Halperin, J. J. (2005). Central nervous system Lyme disease. Curr. Neurol. Neurosci. Rep., 5 (6), 446-452.
    Open DOISearch in Google Scholar
  14. Halperin, J. J, Shapiro, E. D., Logigian, E., Belman, A. L., Dotevall, L., Wormser, G. P., Krupp, L., Gronseth, G., Bever, C. T. Jr. (2007). Practice parameter: Treatment of nervous system Lyme disease (An evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology, 69, 91-102.
    Open DOISearch in Google Scholar
  15. Hu, L. (2005). Lyme arthritis. Infect. Dis. Clin. North Amer., 19 (4), 947-961.
    Open DOISearch in Google Scholar
  16. Klitz, W., Maiers, M., Spellman, S., Baxter-Lowe, L. A., Schmeckpeper, B., Williams, T. M., Fernandez-Vina, M. (2003). New HLA haplotype frequency reference standards: High-resolution and large sample typing of HLA DR-DQ haplotypes in a sample of European Americans. Tissue Antigens. 62, 296-307.
    Open DOISearch in Google Scholar
  17. Kotsch, K., Wehling, J., Blasczyk, R. (1999). Sequencing of HLA class II genes based on the conserved diversity of the non-coding regions: Sequencing based typing of HLA-DRB genes. Tissue Antigens, 53, 486-497.
    Open DOISearch in Google Scholar
  18. Mullegger, R. R. (2004). Dermatological manifestations of Lyme borreliosis. Eur. J. Dermatol., 14, 296-309.
    Search in Google Scholar
  19. Nadelman, R. B., Nowakowski, J., Fish, D., Falco, R. C., Freeman, K., McKenna, D., Welch, P., Marcus, R., Aguero-Rosenfeld, M. E., Dennis, D. T., Wormser, G. P. (2001). Tick Bite Study Group. Prophylaxis with single- dose doxycycline for the prevention of Lyme disease after an Ixodes scapularis tick bite. New Engl. J. Med., 345, 79-84.
    Open DOISearch in Google Scholar
  20. Nowakowski, J., Nadelman, R. B., Sell, R., McKenna, D., Cavaliere, L. F., Holmgren, D., Gaidici, A., Wormser, G. P. (2003). Long-term follow- up of patients with culture-confirmed Lyme disease. Amer. J. Med., 115, 91-96.
    Open DOISearch in Google Scholar
  21. Olerup, O., Aldener, A., Fogdell, A. (1993). HLA-DQB1 and -DQA1 typing by PCR amplification with sequence-specific primers (PCR-SSP). Tissue Antigens, 41 (3), 119-134.
    Open DOISearch in Google Scholar
  22. Oksi, J., Nikoskelainen, J., Hiekkanen, H., Lauhio, A., Peltomaa, M., Pitkäranta, A., Nyman, D., Granlund, H., Carlsson, S. A., Seppälä, I., Valtonen, V., Viljanen, M. (2007). Duration of antibiotic treatment in disseminated Lyme borreliosis: A double-blind, randomized, placebo-controlled, multicenter clinical study. Eur. J. Clin. Microbiol. Infect. Dis., 26, 571-581.
    Open DOISearch in Google Scholar
  23. Philipp, M. T., Wormser, G. P., Marques, A. R., Bittker, S., Martin, D. S., Nowakowski, J.,. Dally, L. G. (2005). A decline in C6 antibody titer occurs in successfully treated patients with culture-confirmed early localized or early disseminated Lyme Borreliosis. Clin. Diagn. Lab. Immunol., 12 (9), 1069-1074.
    Search in Google Scholar
  24. Piacentino, J..D., Schwartz, B. S. (2002). Occupational risk of Lyme disease: An epidemiological review. Occup. Environ. Med., 59 (2), 75-84.
    Open DOISearch in Google Scholar
  25. Qureshi, M. Z., New, D., Zulqarni, N. J., Nachman, S. (2002). Overdiagnosis and overtreatment of Lyme disease in children. Pediatr. Infect. Dis. J., 21, 12-14.
    Open DOISearch in Google Scholar
  26. Schoen, R. T., Sikand, V. K., Caldwell, M. C., Van Hoecke, C., Gillet, M., Buscarino, C., Parenti, D. L. (2000). Safety and immunogenicity profile of a recombinant outer surface protein A Lyme disease vaccine: Clinical trial of a 3-dose schedule at 0, 1, and 2 months. Clin. Therapeutics, 22, 315-325.
    Open DOISearch in Google Scholar
  27. Seltzer, E. G., Gerber, M. A., Cartter, M. L., Freudigman, K., Shapiro, E. D. (2000). Long-term outcomes of persons with Lyme disease. The Journal of the American Medical Association (JAMA), 283, 609-616.
    Open DOISearch in Google Scholar
  28. Sikand, V. K., Halsey, N., Krause, P. J., Sood, S. K., Geller, R., Van Hoecke, C., Buscarino, C., Parenti, D. (2001). Pediatric Lyme Vaccine Study Group. Safety and immunogenicity of a recombinant Borrelia burgdorferi outer surface protein A vaccine against Lyme disease in healthy children and adolescents:Arandomized controlled trial. Pediatrics, 108, 123-128.
    Open DOISearch in Google Scholar
  29. Smith, R. P., Schoen, R. T., Rahn, D. W., Sikand, V. K., Nowakowski, J., Parenti, D. L., Holman, M. S., Persing, D. H., Steere, A. C. (2002). Clinical characteristics and treatment outcome of early Lyme disease in patients with microbiologically confirmed erythema migrans. Ann. Intern. Med., 136, 421-428.
    Open DOISearch in Google Scholar
  30. Steere, A. C. (2001). Lyme disease. New Engl. J. Med., 345, 115-125.
    Open DOISearch in Google Scholar
  31. Steere, A. C., Gross, D, Meyer, A. L., Huber, B. T. (2001). Autoimmune mechanisms in antibiotic treatment-resistant Lyme arthritis. J. Autoimmun., 16, 263-268.
    Open DOISearch in Google Scholar
  32. Steere A. C., Dhar. A, Hernandez, J., Fischer, P. A., Sikand, V. K., Schoen, R. T., Nowakowski, J., McHugh, G., Persing, D. H. (2003). Systemic symptoms without erythema migrans as the presenting picture of early Lyme disease. Amer. J. Med., 114, 58-62.
    Open DOISearch in Google Scholar
  33. Steere, A. C., Falk, B., Drouin, E. E., Baxter-Lowe, L. A., Hammer, J., Nepom, G. T. (2003). Binding of outer surface protein A and human lymphocyte function-associated antigen 1 peptides to HLA-DR molecules associated with antibiotic treatment-resistant Lyme arthritis. Arthritis Rheum., 48, 534-540.
    Open DOISearch in Google Scholar
  34. Steere, A. C., McHugh, G., Suarez, C., Hoitt, J., Damle, N., Sikand, V. K. (2000). Prospective study of coinfection in patients with erythema migrans. Clin. Infect. Dis., 36, 1078-1081.
    Open DOISearch in Google Scholar
  35. Steere, A. C., Klitz ,W., Drouin, E. E., Falk, B. A., Kwok, W. W., Nepom, G. T. Baxter-Lowe, L. A. (2006). Antibiotic-refractory Lyme arthritis is associated with HLA-DR molecules that bind a Borrelia burgdorferi peptide. J. Exp. Med., 203, 961-971.
    Open DOISearch in Google Scholar
  36. Stricker, R. B. (2007). Counterpoint: Long-term antibiotic therapy improves persistent symptoms associated with Lyme disease. Clin. Infect. Dis., 45, 149-157.
    Open DOISearch in Google Scholar
  37. Wormser, G. P., Dattwyler, R. J., Shapiro, E. D., Halperin, J. J., Steere, A. C., Klempner, M. S., Krause, P. J., Bakken, J. S., Strle, F., Stanek, G., Bockenstedt, L., Fish, D., Dumler, J. S., Nadelman, R. B. (2006). The clinical assessment, treatment and prevention of Lyme disease, human granulocytic Anaplasmosis, and Babesiosis: Clinical practice guidelines by the Infectious Diseases Society of America. Clin. Infect. Dis., 43, 1089-1134.
    Open DOISearch in Google Scholar
  38. Wormser, G. P., Nadelman, R. B., Dattwyler, R. J., Dennis, D. T., Shapiro, E. D., Steere, A. C., Rush, T. J., Rahn, D. W., Coyle, P. K., Persing, D. H., Fish, D., Luft, B. J. (2000). Infectious Diseases Society of America Practice Guidelines for the Treatment of Lyme Disease. Clin. Infect. Dis., 31 (Suppl 1), S1-S14. (also available at: www.idsociety.org).
    Search in Google Scholar
  39. Wormser, G. P., Ramanathan, R., Nowakowski, J., McKenna, D., Holmgren, D., Visintainer, P., Dornbush, R., Singh, B., Nadelman, R. B. (2003). Duration of antibiotic therapy for early Lyme disease: A randomized, double- blind, placebo-controlled trial. Ann. Intern. Med., 138, 697-704.
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.1515/prolas-2016-0034 | Journal eISSN: 2255-890X (formerly 1407-009X) | Journal ISSN: 1407-009X
Journal RSS Feed
Language: English
Page range: 215 - 219
Submitted on: Dec 19, 2015
Published on: Aug 4, 2016
Published by: Latvian Academy of Sciences
In partnership with: Paradigm Publishing Services
Keywords:
Lyme borreliosis,
HLA alleles,
PCR-SSP
Related subjects:
Mathematics,
General mathematics

© 2016 Lilija Kovaļčuka, Jeļena Eglīte, Māra Zīālīte, Irina Lucenko, Ludmila Vīksna, Angelika Krūmiņa, published by Latvian Academy of Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Volume 70 (2016): Issue 4 (August 2016)
Previous article
Next article